Maryam Shahi

Dr. Maryam Shahi

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2018 in Cells Tissues Organs
Verified
Journal Article
Closed access
PDF file
MSMaryam Shahi
Maryam Shahi
MNMahmood Nadari
Mahmood Nadari
MSMehdi Sahmani
Mehdi Sahmani
SESeyedjafari Ehsan
Seyedjafari Ehsan
NANaser Ahmadbeigi
Naser Ahmadbeigi
APAmir Peymani
Amir Peymani
The limitation of traditional bone grafts could be overcome by applying engineered bone constructs, which are mainly produced by seeding suitable stem cells on appropriate scaffolds. So far, bone marrow-derived stromal cells have been the most applied cells in bone tissue engineering, but current data show that unrestricted somatic stem cells (USSCs) from human cord blood might actually be a better stem cell source due to the accessibility and noninvasive procedure of collection. In this study, we cultured USSCs on a plasma-treated electrospun polylactic-co-glycolic acid (PLGA) scaffold coated with nanohydroxyapatite (nHA). Adhesion and proliferation of USSCs on PLGA/nHA were assessed by scanning electron microscopy and MTT assay. Osteogenic differentiation of USSCs into osteoblast lineage cells was evaluated via alkaline phosphatase (ALP) activity and real-time polymerase chain reaction. Our observation showed that USSCs attached and proliferated on PLGA/nHA. Osteogenic differentiation was confirmed by increased ALP activity and OSTEONECTIN expression in USSCs on PLGA/nHA after the 1st week of the osteogenic period. Therefore, using USSCs on electrospun PLGA/nHA is a promising approach in bone tissue engineering.

1 April 2013
Verified
Journal Article
Closed access
MSMaryam Shahi
Maryam Shahi
MMMasoud Mohajery
Masoud Mohajery
SSSeyyed Ali Akbar Shamsian
Seyyed Ali Akbar Shamsian
HNHossein Nahrevanian
Hossein Nahrevanian
SYSeyyed Mohammad Javad Yazdanpanah
Seyyed Mohammad Javad Yazdanpanah

Verified
Journal Article
Open access
PDF file
MSMaryam Shahi
Maryam Shahi
ASAzam Shafaei
Azam Shafaei
MGMohamad Ghodsi
Mohamad Ghodsi
REReza Jafarzadeh Esfehani
Reza Jafarzadeh Esfehani
MMMahdi Moradi Marjaneh
Mahdi Moradi Marjaneh
Introduction: Human papillomavirus (HPV) genotyping is critical for preventing and managing HPV-related health issues, including cancers. This study re-evaluates HPV genotype trends in Iran to inform prevention strategies. Materials and Methods: A cross-sectional analysis of HPV genotyping data from individuals tested at the ACECR Khorasan Razavi molecular laboratory in Iran (2016–2022) was conducted, with a forecast of genotype trends through 2027. Results: Among 5009 female patients, 40.4% tested positive for HPV (mean age: 32 ± 8.77 years), with a significant upward trend in positivity over time (tau = 0.905, p = 0.0069). HPV 6, 11, 16, 31, 53, and 54 showed significant increases (p < 0.01), while HPV 66, 84, 67, and 35 exhibited notable trends (p < 0.05). HPV 18 and 33 had marginal trends (p = 0.065, p = 0.052), and HPV 68, 70, and 82 remained stable. Linear regression indicated a non-significant decline in low-risk HPV cases (R = 0.703, p = 0.078) and negligible change in high-risk cases (R = 0.052, p = 0.912). Forecasts predicted increases in HPV 84, 54, 43, 42, and 26, with HPV 6 projected to decrease significantly. HPV 44, 73, and 33 were expected to remain stable. Conclusion: While low-risk HPV cases may decline, the trend lacks statistical significance, and high-risk HPV cases show no change. These findings underscore the need for targeted prevention strategies in Iran, particularly for high-risk genotypes, to reduce the burden of HPV-related cancers. Further research is essential to validate these trends and refine public health interventions.

19 July 2023 in International Journal of Reproductive BioMedicine (IJRM)
Verified
Journal Article
Open access
ASAzam Shafaei
Azam Shafaei
SSSeyyed Ali Akbar Shamsian
Seyyed Ali Akbar Shamsian
MGMohammad Ghodsi
Mohammad Ghodsi
FSFatemeh Sadabadi
Fatemeh Sadabadi
MSMaryam Shahi
Maryam Shahi
Background: Sexually transmitted infections (STIs) are one of the world’s most severe health challenges. The existence of STIs such as human papillomavirus (HPV) might cause cervical cell changes leading to cervical cancer. Objective: This study aims to assess the association of STIs with cervical cytological abnormalities and genital warts among women in northeastern Iran. Materials and Methods: This cross-sectional study was carried out on 190 women referred to the central laboratory of Academic Center for Education, Culture, and Research, Mashhad, Iran from March to July 2022. The presence of genital infections caused by Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Herpes simplex viruses (1 and 2) were assessed using the real-time polymerase chain reaction method. HPV genital infection was detected based on the principles of reverse hybridization, and cellular changes in the cervix were examined by the liquid-based cytology technique. Results: The mean age of participants was 35.33 ± 8.9 yr. 34 different HPV genotypes were detected in all HPV-positive cases, and the most common genotype was low-risk HPV6. No significant association was found between STIs and cervical cytology abnormalities. The prevalence rates of sexually transmitted pathogens among HPV-positive and HPV-negative individuals were 10.9 and 1.6%, respectively. The frequency of genital warts was significantly higher in cases with multiple infections of high- and low-risk HPV genotypes. Conclusion: High percentages of the participants with non-HPV STIs and HPV infection had normal cervical cytology. It is advised to use STIs and HPV diagnostic tests along with cytology examinations for cervical cancer screening. Key words: Sexually transmitted infections, Human papillomavirus, Cervical cancer, Genital wart, Genotypes.